N-acetylcysteine (NAC) ameliorates Epstein-Barr virus latent membrane protein 1 induced chronic inflammation
Table 1
L2LMP1 transgenic mice were designated with numbers I to VII (as indicated). Treatment with NAC (from 48 days old) or untreated is indicated (+,—respectively) and ear stage at age 103 days. Mice I to VI were recipients for leukocytes (cells inj) collected from donor L2LMP1 stage 5 ears.